Stem cell therapy has attracted increasing attention as a promising treatment strategy for
cardiac repair in ischemic heart disease. Nanoparticles (NPs), with their superior physical …

Objectives: This study aims to provide insight into cellular kinetics using molecular imaging
after different transplantation methods of bone marrow–derived mononuclear cells (MNCs) …

Aim: To investigate the survival of bone marrow mesenchymal stem cells (BMSCs) and the
therapeutic effect for acute myocardial infarction (AMI) after co-transplantation with the …

Stem cell therapy efficiently targets the brain for most neurological disorders like migraine,
Parkinsonism, schizophrenia, Alzheimer's disease, and brain injury. The major obstacles in …

Neurodegenerative diseases called tauopathies, such as Alzheimer's disease (AD),
frontotemporal dementia, progressive supranuclear palsy, and Parkinson's disease, among …

Oxidative injury to cardiomyocytes plays a critical role in cardiac pathogenesis following
myocardial infarction. Transplantation of stem cell-derived cardiomyocytes has recently …

Bone marrow mononuclear cell (BM-MNC) therapy in ST-elevation acute myocardial
infarction (STEMI) has no biological inclusion criteria. Here, we analyzed 63 biomarkers and …

Human cardiomyocytes derived from pluripotent stem cells hold great promise for cardiac
cell therapy, disease modeling, drug discovery, and the study of developmental biology …

Background—Human cardiac progenitor cells (hCPCs) are a promising cell source for
regenerative repair after myocardial infarction. Exploitation of their full therapeutic potential …

Design and implementation of an environmental monitoring program is vital to assure the
maintenance of acceptable quality conditions in a pharmaceutical manufacturing unit of …